J.Gy. Papp
Hungarian Academy of Sciences
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by J.Gy. Papp.
Acta Physiologica | 2008
Cs. Lengyel; László Virág; Peter Kovacs; Attila Kristóf; Pál Pacher; Erzsébet Kocsis; Zs. M. Koltay; Péter P. Nánási; Magdolna Tóth; Valéria Kecskeméti; J.Gy. Papp; András Varró; Norbert Jost
Aim: In diabetes mellitus, several cardiac electrophysiological parameters are known to be affected. In rodent experimental diabetes models, changes in these parameters were reported, but only limited relevant information is available in other species, having cardiac electrophysiological properties more resembling the human, including the rabbit. The present study was designed to analyse the effects of experimental type 1 diabetes on ventricular repolarization and the underlying transmembrane potassium currents in rabbit hearts.
British Journal of Pharmacology | 2013
Norbert Jost; Norbert Nagy; Claudia Corici; Zsófia Kohajda; Aniko Horvath; Károly Acsai; Péter Biliczki; Jouko Levijoki; Piero Pollesello; Tuula Koskelainen; Leena Otsomaa; András Tóth; J.Gy. Papp; András Varró; László Virág
At present there are no small molecule inhibitors that show strong selectivity for the Na+/Ca2+ exchanger (NCX). Hence, we studied the electrophysiological effects of acute administration of ORM‐10103, a new NCX inhibitor, on the NCX and L‐type Ca2+ currents and on the formation of early and delayed afterdepolarizations.
Inflammation Research | 1979
M. Wollemann; J.Gy. Papp
ConclusionsThe results support the view that in man cardiac responsiveness to histamine appears at a very early stage of development. It might also be suggested that in human embryonic and foetal hearts the adenylate cyclase activating, positive chronotropic and ventricular inotropic effects of histamine are mediated via H2-type histaminergic receptors.
Journal of Molecular and Cellular Cardiology | 1975
M. Wollemann; J. Borbola; J.Gy. Papp; L. Szekeres
Abstract The effect of beta-adrenergic receptor agonists (isoproterenol, hexoprenaline, salbutamol) on the adenylate cyclase activity and some functional parameters of the atrial and ventricular myocardium of the rabbit was investigated. The influence of isoproterenol was studied also in the presence of beta-adrenergic receptor antagonists (practolol, pindolol). The beta-adrenergic stimulants had a similar decreasing order of relative potency (isoproterenol > hexoprenaline > salbutamol) in stimulating atrial or ventricular adenylate cyclase, in increasing atrial or ventricular contractility, spontaneous atrial rate, the maximum driving frequency of the ventricular myocardium and in reducing ventricular electrical threshold. Isoproterenol proved to be the most potent adrenergic agonist also in decreasing atrial electrical threshold, but in this respect salbutamol was slightly more active than hexoprenaline. Practolol and pindolol inhibited the effects of isoproterenol on adenylate cyclase activity and also on the functional parameters. Some statistical correlation was also found between the adrenergically-induced rise in cyclic AMP levels and the corresponding changes in the physiological functions of the myocardium. However, concentrations of the studied adrenergic agonists required to equally activate adenylate cyclase produced significantly different effects on the functional parameters, and analysis of the results has shown that the observed correlations reflect, at least in part, parallel processes rather than an exclusive cause and effect relationship.
Acta Physiologica | 2008
János Pataricza; Zoltán Márton; Cs. Lengyel; Magdolna Tóth; J.Gy. Papp; András Varró; Attila Kun
Aims: Functional roles of calcium‐activated potassium channels on the mechanical activity of epicardial coronary arteries obtained from a canine model of diabetes were investigated.
Journal of Molecular Structure-theochem | 2000
L.L. Torday; Botond Penke; Graciela N. Zamarbide; R.D. Enriz; J.Gy. Papp
Abstract Ab initio conformational analysis has been carried out on 3-mercapto-propanamide, ( R )- and ( S )-2-methyl-3-mercapto-propanamide as well as their S -deprotonated conjugate basis. They were carried out at the HF/3-21G level of theory. The topology of the conformational potential energy surfaces and hypersurfaces have been analysed.
Archive | 1987
L. Szekeres; J.Gy. Papp; Éva Udvary; Á. Végh
The marked coronary dilating and negative inotropic effect of prenylamine /1/ as well as that of verapamil /2/ was described in the early sixties, however Fleckenstein et al. /3/ were the first to show that these agents are capable of depressing cardiac contractility in concentrations not yet affecting the action potential. Thus they inhibit the electromechanical coupling. The authors attributed this effect to a drug induced depression of the transmembrane inward Ca2+ current hence the name: calcium antagonists /Ca-s/. Later Grun and Fleckenstein /4/ have shown electromechanical uncoupling effect of CA-s in the smooth muscle too. The steadily growing interest has initiated a number of experimental and clinical studies showing that in addition to its scientific importance introduction of this new group of drugs into clinical therapy represents a major breakthrough.
Acta Physiologica Scandinavica | 1996
Péter P. Nánási; Csaba Pankucsi; Tamás Bányász; Péter Szigligeti; J.Gy. Papp; András Varró
European Physical Journal D | 2002
David H. Setiadi; Gregory A. Chass; L.L. Torday; András Varró; J.Gy. Papp; Imre G. Csizmadia
Acta Physiologica Scandinavica | 2004
Klára Csete; Z. Vezekenyi; T. Doczi; J.Gy. Papp; M. Bodosi; Pál Barzó